Exscientia: Disrupting the PharmaTech Industry

Existentia, a pharmatech company, increased awareness of the brand in the UK ahead of announcing its drug breakthrough.

Objective

In January 2020, our client Exscientia was ready to announce a world-first: their precision-engineered drug, designed using artificial intelligence (AI), was about to enter Phase 1 clinical trials.

With less than three weeks to craft a compelling narrative and media strategy, we set a central PR objective for the news: position the growing company as an undisputed leader within the AI drug discovery space, particularly for the target pharmaceutical industry and investor audiences.

Yet, this exciting milestone presented us with a communications challenge.

Founded in 2012, Exscientia is a UK-based leading pharmatech company using proprietary AI technology to...

WARC subscribers can sign in to keep reading

Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands